Zydus joins the pack in India hep C launch; Vivo Capital raises $750M for U.S., Greater China;

> Zydus launched its hep C drug in India under Gilead ($GILD) license. Story

> Vivo Capital raises $750 million in 8th fund focused on U.S., Greater China. Release

> Mundipharma touted Betadine formulations effectiveness in minimizing risk of human-to-human Ebola transmission. Release (PDF)

> TaiGen signs agreement with Cellex and the University Hospital Carl Gustav Carus Dresden in Germany in an investigator-initiated stem cell clinical trial. Release

> Australia's Mesoblast wins Japan External Trade Organization fast-track status on stem-cell investments. Release

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.